REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/20/2026
Back to search
Official data from USPTO
THE LEPTIN DIET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE LEPTIN DIET
ST13
US500000078409278Class
16
Filing
78409278
Registration
3220889
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/21/2026
Trademark type
Word
Nice classes
16
Filing date
04/28/2004
Registration date
03/20/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/03/2016
Last transaction
03/21/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
04/27/2004
First use in commerce
04/27/2004
Drawing code
4
Owner type
03
Owner location
Minneapolis, MN, US
Examiner
TURNER, JASON FITZGERALD
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Wellness Resources, Inc.
Wellness Resources, Inc.
Representatives
Kathryn K. Smith Sherrill Law Offices, PLLC
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed instructionaleducationalteaching materials in the field of weight management and disease prevention
Publications
History of USPTO decisions and trademark events.
43 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/03/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/03/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/03/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/03/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
05/12/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/20/2016
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/02/2013
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/02/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/28/2013
ES8R
TEAS SECTION 8 RECEIVED
03/18/2013
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/20/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2007
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/02/2007
IUAA
USE AMENDMENT ACCEPTED
02/02/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
01/18/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/18/2007
ALIE
ASSIGNED TO LIE
01/18/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2006
GNRT
NON-FINAL ACTION E-MAILED
11/27/2006
CNRT
NON-FINAL ACTION WRITTEN
11/27/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/25/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/21/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/21/2006
DOCK
ASSIGNED TO EXAMINER
09/15/2006
GNRU
DISAPPROVAL - AMENDMENT TO USE E-MAILED
03/21/2006
CNRT
NON-FINAL ACTION WRITTEN
03/21/2006
AAUD
AMENDMENT OF ALLEGED USE DISAPPROVED
01/24/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2005
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/27/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/14/2005
IUAF
USE AMENDMENT FILED
12/14/2005
EAAU
TEAS AMENDMENT OF USE RECEIVED
12/14/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2005
GNFR
FINAL REFUSAL E-MAILED
07/25/2005
CNFR
FINAL REFUSAL WRITTEN
07/25/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/22/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2005
GNRT
NON-FINAL ACTION E-MAILED
12/13/2004
CNRT
NON-FINAL ACTION WRITTEN
12/13/2004
DOCK
ASSIGNED TO EXAMINER
11/23/2004
NWAP
NEW APPLICATION ENTERED
05/05/2004
Continuous trademark protection
Get notified about every new filing that threatens THE LEPTIN DIET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.